JP2018043949A5 - - Google Patents

Download PDF

Info

Publication number
JP2018043949A5
JP2018043949A5 JP2016180306A JP2016180306A JP2018043949A5 JP 2018043949 A5 JP2018043949 A5 JP 2018043949A5 JP 2016180306 A JP2016180306 A JP 2016180306A JP 2016180306 A JP2016180306 A JP 2016180306A JP 2018043949 A5 JP2018043949 A5 JP 2018043949A5
Authority
JP
Japan
Prior art keywords
improving
extract
composition
blood flow
lemon myrtle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016180306A
Other languages
Japanese (ja)
Other versions
JP2018043949A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2016180306A priority Critical patent/JP2018043949A/en
Priority claimed from JP2016180306A external-priority patent/JP2018043949A/en
Publication of JP2018043949A publication Critical patent/JP2018043949A/en
Publication of JP2018043949A5 publication Critical patent/JP2018043949A5/ja
Pending legal-status Critical Current

Links

Claims (9)

レモンマートル抽出物、ドクダミ抽出物、ヨモギ抽出物、ワイルドストロベリー抽出物、ラズベリーリーフ抽出物、エキナセア抽出物、及びクミスクチン抽出物からなる群より選択される少なくとも１種を含む、血流改善用、むくみ改善用、リンパ流改善用、体のこり改善用、冷え改善用、又は肌のしわ、たるみ若しくは荒れ改善用の組成物。 For improving blood flow and improving swelling, including at least one selected from the group consisting of Lemon Myrtle extract, Dokudami extract, Artemisia extract, Wild strawberry extract, Raspberry leaf extract, Echinacea extract, and Cumistin extract A composition for improving blood flow, improving lymph flow, improving body stiffness, improving cold, or improving wrinkles, sagging or roughness of skin . 少なくとも、レモンマートル抽出物、ワイルドストロベリー抽出物、及びラズベリーリーフ抽出物からなる群より選択される少なくとも１種を含む、請求項１に記載の組成物。 The composition according to claim 1, comprising at least one selected from the group consisting of a lemon myrtle extract, a wild strawberry extract, and a raspberry leaf extract. 経口組成物である、請求項１又は２に記載の組成物。 The composition according to claim 1 or 2, which is an oral composition. 医薬組成物又は食品組成物である、請求項１〜３のいずれかに記載の組成物。 The composition according to any one of claims 1 to 3, which is a pharmaceutical composition or a food composition. レモンマートル、ドクダミ、ヨモギ、ワイルドストロベリー、ラズベリーリーフ、エキナセア、及びクミスクチンからなる群より選択される少なくとも１種を、水、エタノール、又は水−エタノール混合液による抽出に供する工程を含む、血流改善用、むくみ改善用、リンパ流改善用、体のこり改善用、冷え改善用、又は肌のしわ、たるみ若しくは荒れ改善用の組成物の製造方法。 For improving blood flow , comprising a step of subjecting at least one selected from the group consisting of lemon myrtle, dokudami, mugwort, wild strawberry, raspberry leaf, echinacea, and cumistin to extraction with water, ethanol, or a water-ethanol mixture . A method for producing a composition for improving swelling, improving lymph flow, improving body stiffness, improving cold, or improving wrinkles, sagging or roughness of skin . レモンマートル、ドクダミ、ヨモギ、ワイルドストロベリー、ラズベリーリーフ、エキナセア、及びクミスクチンからなる群より選択される少なくとも１種の乾燥物を含む、血流改善用、むくみ改善用、リンパ流改善用、体のこり改善用、冷え改善用、又は肌のしわ、たるみ若しくは荒れ改善用の乾燥茶葉又はティーバッグ。 Lemon Myrtle, Dokudami, Artemisia, Wild Strawberry, Raspberry Leaf, Echinacea, and at least one dried product selected from the group consisting of cumistin, for improving blood flow, improving swelling, improving lymph flow, and improving body stiffness Dry tea leaves or tea bags for improving cold, improving wrinkles, sagging or roughness of skin . 血流改善用である、請求項１〜４のいずれかに記載の組成物。 It is for improving blood flow, composition according to any one of claims 1 to 4. 少なくともレモンマートル抽出物を含む、請求項１〜４のいずれかに記載の組成物。The composition in any one of Claims 1-4 containing a lemon myrtle extract at least. レモンマートル抽出物を含む、血流改善用組成物。A composition for improving blood flow, comprising a lemon myrtle extract.
JP2016180306A 2016-09-15 2016-09-15 COMPOSITION FOR ACTIVATING Tie2 Pending JP2018043949A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2016180306A JP2018043949A (en) 2016-09-15 2016-09-15 COMPOSITION FOR ACTIVATING Tie2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016180306A JP2018043949A (en) 2016-09-15 2016-09-15 COMPOSITION FOR ACTIVATING Tie2

Publications (2)

Publication Number Publication Date
JP2018043949A JP2018043949A (en) 2018-03-22
JP2018043949A5 true JP2018043949A5 (en) 2019-08-15

Family

ID=61693512

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016180306A Pending JP2018043949A (en) 2016-09-15 2016-09-15 COMPOSITION FOR ACTIVATING Tie2

Country Status (1)

Country Link
JP (1) JP2018043949A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7154906B2 (en) * 2018-03-30 2022-10-18 株式会社ナリス化粧品 Skin sagging improving agent and screening method thereof
WO2019235856A1 (en) 2018-06-07 2019-12-12 기초과학연구원 Antibody binding to tie2 and use thereof
EP4335871A1 (en) 2021-05-06 2024-03-13 Institute for Basic Science Tie2 agonistic antibodies and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010092941A1 (en) * 2009-02-16 2010-08-19 株式会社 ブルボン Composition having vasodilation activity, process for producing same, and use of same
JP2010202520A (en) * 2009-02-27 2010-09-16 Kaneka Corp Skin improver and oral composition for cosmetic and health purposes
JP6640730B2 (en) * 2014-10-16 2020-02-05 サントリーホールディングス株式会社 Tie2 activator containing olive fruit extract

Similar Documents

Publication Publication Date Title
JP2018043949A5 (en)
WO2016168784A3 (en) Rna nanoparticles and method of use thereof
RU2015107026A (en) TOBACCO EXTRACT, ITS PRODUCTION
RU2019122808A (en) A PHARMACEUTICAL COMPOSITION CONTAINING INDIGO PULVERATA LEVIS EXTRACT OR ITS FRACTION AS AN EFFECTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY INTESTINAL DISEASE
JP2018035153A5 (en)
JP2010233921A5 (en)
Wang et al. Outstanding female cancer research paper awards of the 2016 Taiwan Association of Obstetrics and Gynecology and Hsu Chien-Tien Cancer Foundation
ITUA20162542A1 (en) SYSTEM TO DETECT AND MEASURE THE PERMANENCE OF A PERSON WITHIN AN AREA, IN PARTICULAR A WIND TUNNEL, AND ITS METHOD.
Park et al. Stability evaluation of cefaclor dry syrup after opening with simulation design
US9585924B1 (en) Herbal water beverage
FR2927331B1 (en) NOVEL ANTI-INFECTIOUS DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPEUTICS
Khongkhon et al. Inhibition of LPS-induced nitric oxide production in RAW 264.7 cell lines, DPPH radical scavenging and total phenolic content of banana (Musa sapientum) blossom extracts
Singh et al. Comparative anthelmintic activity of Aegle marmelos Linn leaves and pulp
Wang et al. Outstanding research paper awards of the 2014 Taiwanese Journal of Obstetrics and Gynecology
RU2016122783A (en) The method of obtaining kefir with nanostructured extract of dry rosehip
CN105973753A (en) Kit for rapidly detecting blood viscosity
Zhilyakova et al. Investigation of morphology and porous structure of medical clays
Tomaro-Duchesneau et al. Modification of the gut microbiota to promote human health
Belaaouaj et al. B45 COPD: PATHOGENESIS: Study Of Cytosolic Phospholipase A2 [alpha] Role In COPD Exacerbations Using A Cell Culture Model
Oliveira et al. C30 ACUTE LUNG INJURY: CELL FUNCTION, SIGNALING AND STRETCH: Effects Of Bacterial LPS On The Biomechanics Of Alveolar Epithelial Cells Measured By Atomic Force Microscopy
Hile The gates of headley grange
Randall 'The living presence of Christ': Charles Raven (1885-1964), a missional theologian.
Park Eucharist is Giving
Markland et al. Erratum to: Reversal of Thienopyridine-Induced Platelet Dysfunction Following Desmopressin Administration
Van Pottelbergh et al. Where do we stand after five years of care trajectories for patients with chronic kidney disease?